175 related articles for article (PubMed ID: 36917093)
1. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue.
Ma S; Zhao H; Wang F; Peng L; Zhang H; Wang Z; Jiang F; Zhang D; Yin M; Li S; Huang J; Liu Z; Tao S
Aging (Albany NY); 2023 Mar; 15(5):1628-1651. PubMed ID: 36917093
[TBL] [Abstract][Full Text] [Related]
2. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
[TBL] [Abstract][Full Text] [Related]
3. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
4. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
5. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
7. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
8. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
[TBL] [Abstract][Full Text] [Related]
9. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
10. Pyroptosis-related lncRNAs: A novel prognosis signature of colorectal cancer.
Cai X; Liang X; Wang K; Liu Y; Hao M; Li H; Dai X; Ding L
Front Oncol; 2022; 12():983895. PubMed ID: 36531020
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
12. A pyroptosis-related lncRNA signature in bladder cancer.
Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Qu G; Wang D; Xu W; Guo W
Front Genet; 2022; 13():867627. PubMed ID: 35559014
[No Abstract] [Full Text] [Related]
14. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature.
Zhang Z; Shang J; Hu B; Shi H; Cao Y; Li J; Jiao T; Zhang W; Lu S
Front Immunol; 2022; 13():836576. PubMed ID: 35812396
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
[TBL] [Abstract][Full Text] [Related]
16. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
18. A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma.
Zhong J; Liu J; Huang Z; Zheng Y; Chen J; Ji J; Chen T; Ke Y
Front Genet; 2022; 13():1026192. PubMed ID: 36353102
[No Abstract] [Full Text] [Related]
19. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma.
Shen L; Li Y; Li N; Zhao Y; Zhou Q; Shen L; Li Z
Sci Rep; 2022 Mar; 12(1):4527. PubMed ID: 35296768
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
